News
In the face of thousands of lawsuits in its role in the opioid addiction crisis, Purdue Pharma announced yesterday that it has filed for...
The FDA’s Allergenic Products Advisory Committee (APAC) has recommended the use of Aimmune Therapeutics’ AR101, also known by its proposed brand name...
Lundbeck is to buy Alder Biopharmaceuticals for $2 billion enhancing its leading portfolio of brain disease therapies through the acquisition of...
Amgen has revealed new Phase 3 data for the combination of Kyprolis (carfilzomib) and Darzalex (daratumumab) in addition to the steroid...
Novartis’ multiple sclerosis candidate has demonstrated strong results in its Phase 3 ASCLEPIOS trials meeting primary endpoints and slashing the...
Roche has taken the opportunity at the ECTRIMS conference in Stockholm to reveal new longer-term data from three Phase 3 trials demonstrating that...
It’s Friday again and time for another rundown of the top most popular articles on Pharmafile.com this week. This past week saw Novo Nordisk launch...
Sir Mark Walport, Chief Executive of UK Research and Innovation (UKRI), the national funding agency responsible for science and research investment...
Ardelyx announced that it has received FDA approval for its NHE3 sodium transport inhibitor Isbrela (tenapanor) for the treatment of irritable bowel...
Johnson & Johnson subsidiary Janssen have announced results from its Phase 3 OPTIMUM trial showing superior efficacy to Sanofi’s Aubagio (...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
